We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current 0QN1 market cap is 2.15B. The company's latest EPS is CHF 4.8415 and P/E is 1.95.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
| Total Revenue | 75.38M | 15.01M | -1.6M | 7.47M | 103.41M |
| Operating Income | -10.44M | -53.08M | -56.89M | -51.98M | 51.16M |
| Net Income | -18.97M | -67.66M | -55.53M | -71.08M | 54.78M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
| Total Assets | 115.05M | 88.69M | 91.12M | 63.73M | 109.63M |
| Total Liabilities | 93.8M | 95.04M | 89.79M | 107.41M | 49.69M |
| Total Equity | 21.25M | -6.35M | 1.33M | -43.69M | 59.94M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
| Operating | 2.6M | -43.51M | -37.36M | -29.84M | 47.27M |
| Investing | 2.79M | 1.56M | 69k | -3.93M | -18.04M |
| Financing | 4.13M | 23.15M | 46.02M | 13.99M | -171k |
| Market Cap | 2.15B |
| Price to Earnings Ratio | 1.95 |
| Price to Sales Ratio | 1.03 |
| Price to Cash Ratio | 3.51 |
| Price to Book Ratio | 1.78 |
| Dividend Yield | - |
| Shares Outstanding | 11.32M |
| Average Volume (1 week) | 831 |
| Average Volume (1 Month) | 1.02k |
| 52 Week Change | 0.00% |
| 52 Week High | 190.20 |
| 52 Week Low | 190.20 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Santhera Pharmaceuticals Holding Ag |
| Address |
hammerstrasse 49 liestal 4410 |
| Website | https://www.santhera.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
